• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的表观遗传特征:合适的对照、当前的挑战和临床转化的潜力。

Epigenetic signatures in cancer: proper controls, current challenges and the potential for clinical translation.

机构信息

Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Faculty of Biosciences, Ruprecht-Karls-University of Heidelberg, 69120, Heidelberg, Germany.

出版信息

Genome Med. 2021 Feb 10;13(1):23. doi: 10.1186/s13073-021-00837-7.

DOI:10.1186/s13073-021-00837-7
PMID:33568205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7874645/
Abstract

Epigenetic alterations are associated with normal biological processes such as aging or differentiation. Changes in global epigenetic signatures, together with genetic alterations, are driving events in several diseases including cancer. Comparative studies of cancer and healthy tissues found alterations in patterns of DNA methylation, histone posttranslational modifications, and changes in chromatin accessibility. Driven by sophisticated, next-generation sequencing-based technologies, recent studies discovered cancer epigenomes to be dominated by epigenetic patterns already present in the cell-of-origin, which transformed into a neoplastic cell. Tumor-specific epigenetic changes therefore need to be redefined and factors influencing epigenetic patterns need to be studied to unmask truly disease-specific alterations. The underlying mechanisms inducing cancer-associated epigenetic alterations are poorly understood. Studies of mutated epigenetic modifiers, enzymes that write, read, or edit epigenetic patterns, or mutated chromatin components, for example oncohistones, help to provide functional insights on how cancer epigenomes arise. In this review, we highlight the importance and define challenges of proper control tissues and cell populations to exploit cancer epigenomes. We summarize recent advances describing mechanisms leading to epigenetic changes in tumorigenesis and briefly discuss advances in investigating their translational potential.

摘要

表观遗传改变与衰老或分化等正常生物学过程有关。全球表观遗传特征的变化,加上遗传改变,正在推动包括癌症在内的几种疾病的发展。对癌症和健康组织的比较研究发现,DNA 甲基化、组蛋白翻译后修饰和染色质可及性的变化模式发生了改变。在基于高通量测序技术的推动下,最近的研究发现,癌症表观基因组主要由起源细胞中已经存在的表观遗传模式驱动,这些模式转化为肿瘤细胞。因此,需要重新定义肿瘤特异性表观遗传改变,并研究影响表观遗传模式的因素,以揭示真正的疾病特异性改变。诱导与癌症相关的表观遗传改变的潜在机制知之甚少。对突变的表观遗传修饰物(例如,能够书写、读取或编辑表观遗传模式的酶)或突变的染色质成分(例如癌组蛋白)的研究有助于提供关于癌症表观基因组如何产生的功能见解。在这篇综述中,我们强调了正确控制组织和细胞群体的重要性,并定义了利用癌症表观基因组的挑战。我们总结了描述肿瘤发生过程中导致表观遗传变化的机制的最新进展,并简要讨论了研究其转化潜力的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03bd/7874645/243a3045fd12/13073_2021_837_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03bd/7874645/c5cddb332d36/13073_2021_837_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03bd/7874645/aef4b1efdf93/13073_2021_837_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03bd/7874645/243a3045fd12/13073_2021_837_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03bd/7874645/c5cddb332d36/13073_2021_837_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03bd/7874645/aef4b1efdf93/13073_2021_837_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03bd/7874645/243a3045fd12/13073_2021_837_Fig3_HTML.jpg

相似文献

1
Epigenetic signatures in cancer: proper controls, current challenges and the potential for clinical translation.癌症中的表观遗传特征:合适的对照、当前的挑战和临床转化的潜力。
Genome Med. 2021 Feb 10;13(1):23. doi: 10.1186/s13073-021-00837-7.
2
Genome-wide epigenetic modifications in cancer.癌症中的全基因组表观遗传修饰
Prog Drug Res. 2011;67:25-49. doi: 10.1007/978-3-7643-8989-5_2.
3
Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.癌症化学预防与营养表观遗传学:现状与未来挑战
Top Curr Chem. 2013;329:73-132. doi: 10.1007/128_2012_360.
4
Cancer epigenetics: linking basic biology to clinical medicine.癌症表观遗传学:将基础生物学与临床医学联系起来。
Cell Res. 2011 Mar;21(3):502-17. doi: 10.1038/cr.2011.24. Epub 2011 Feb 15.
5
Epigenetic dysregulation in cancer.癌症中的表观遗传失调。
Am J Pathol. 2009 Oct;175(4):1353-61. doi: 10.2353/ajpath.2009.081142. Epub 2009 Aug 28.
6
Unraveling the epigenetic code of cancer for therapy.破解癌症的表观遗传密码用于治疗。
Trends Genet. 2007 Sep;23(9):449-56. doi: 10.1016/j.tig.2007.07.005. Epub 2007 Aug 6.
7
Investigation of epigenetics in kidney cell biology.肾细胞生物学中的表观遗传学研究。
Methods Cell Biol. 2019;153:255-278. doi: 10.1016/bs.mcb.2019.04.015. Epub 2019 Jun 13.
8
Pharmaco-epigenomics: On the Road of Translation Medicine.药物-表观基因组学:转化医学之路。
Adv Exp Med Biol. 2019;1168:31-42. doi: 10.1007/978-3-030-24100-1_3.
9
Epigenomic technologies for precision oncology.表观基因组学技术在精准肿瘤学中的应用。
Semin Cancer Biol. 2022 Sep;84:60-68. doi: 10.1016/j.semcancer.2020.08.004. Epub 2020 Aug 18.
10
Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007.表观遗传学与癌症,第二届国际癌症研究机构会议,法国里昂,2007年12月6日至7日
Mol Oncol. 2008 Jun;2(1):33-40. doi: 10.1016/j.molonc.2008.03.005. Epub 2008 Mar 27.

引用本文的文献

1
Reflections and perspectives on epigenetically mediated biological control: compromises in cancer and skeletal pathology.关于表观遗传介导的生物控制的思考与展望:癌症与骨骼病理学中的权衡
Acad Biol. 2025;3(2). doi: 10.20935/AcadBiol7628. Epub 2025 Apr 11.
2
Epi-nutrients for cancer prevention: Molecular mechanisms and emerging insights.用于癌症预防的表型营养素:分子机制与新见解
Cell Biol Toxicol. 2025 Jul 15;41(1):116. doi: 10.1007/s10565-025-10054-2.
3
High-throughput epigenetic profiling immunoassays for accelerated disease research and clinical development.

本文引用的文献

1
Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone.全球改变的表观遗传景观和 H3.3-G34W 突变性骨巨细胞瘤中延迟的成骨分化。
Nat Commun. 2020 Oct 27;11(1):5414. doi: 10.1038/s41467-020-18955-y.
2
Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases.机器学习分析 DNA 甲基化图谱可区分原发性肺鳞癌和头颈部转移。
Sci Transl Med. 2019 Sep 11;11(509). doi: 10.1126/scitranslmed.aaw8513.
3
Cell-type-specific resolution epigenetics without the need for cell sorting or single-cell biology.
用于加速疾病研究和临床开发的高通量表观遗传学分析免疫测定法。
J Biol Chem. 2025 Jun 7;301(7):110352. doi: 10.1016/j.jbc.2025.110352.
4
The Metabolic Landscape of Cancer Stem Cells: Insights and Implications for Therapy.癌症干细胞的代谢格局:对治疗的见解与启示
Cells. 2025 May 15;14(10):717. doi: 10.3390/cells14100717.
5
Programmable mRNA therapeutics for controlled epigenomic modulation of single and multiplexed gene expression in diverse diseases.用于在多种疾病中对单基因和多基因表达进行可控表观基因组调控的可编程mRNA疗法。
Nat Commun. 2025 Mar 13;16(1):2517. doi: 10.1038/s41467-025-57920-5.
6
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence.肿瘤休眠与复发:理解癌症复发的分子机制
Mil Med Res. 2025 Feb 11;12(1):7. doi: 10.1186/s40779-025-00595-2.
7
HOXD1 inhibits lung adenocarcinoma progression and is regulated by DNA methylation.HOXD1 抑制肺腺癌进展,受 DNA 甲基化调控。
Oncol Rep. 2024 Dec;52(6). doi: 10.3892/or.2024.8832. Epub 2024 Oct 25.
8
Non-Coding RNAs and Innate Immune Responses in Cancer.癌症中的非编码RNA与先天免疫反应
Biomedicines. 2024 Sep 11;12(9):2072. doi: 10.3390/biomedicines12092072.
9
Therapeutic Opportunities for Biomarkers in Metastatic Spine Tumors.转移性脊柱肿瘤生物标志物的治疗机会
Cancers (Basel). 2024 Sep 14;16(18):3152. doi: 10.3390/cancers16183152.
10
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.从隐窝到癌症:结直肠癌发生和治疗策略的整体观点。
Int J Mol Sci. 2024 Aug 30;25(17):9463. doi: 10.3390/ijms25179463.
无需细胞分选或单细胞生物学即可实现基于细胞类型的分辨率表观遗传学研究。
Nat Commun. 2019 Jul 31;10(1):3417. doi: 10.1038/s41467-019-11052-9.
4
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia.衰老的人类造血干细胞表现出增强子的深刻表观遗传重编程,这可能导致白血病。
Cancer Discov. 2019 Aug;9(8):1080-1101. doi: 10.1158/2159-8290.CD-18-1474. Epub 2019 May 13.
5
Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).利用循环肿瘤 DNA(ctDNA)高通量靶向 DNA 甲基化测序进行早期肺癌的无创诊断。
Theranostics. 2019 Apr 6;9(7):2056-2070. doi: 10.7150/thno.28119. eCollection 2019.
6
Epigenetic Enzyme Mutations: Role in Tumorigenesis and Molecular Inhibitors.表观遗传酶突变:在肿瘤发生中的作用及分子抑制剂
Front Oncol. 2019 Mar 29;9:194. doi: 10.3389/fonc.2019.00194. eCollection 2019.
7
The expanding landscape of 'oncohistone' mutations in human cancers.人类癌症中“肿瘤组蛋白”突变的扩展领域。
Nature. 2019 Mar;567(7749):473-478. doi: 10.1038/s41586-019-1038-1. Epub 2019 Mar 20.
8
Accumulation of genetic and epigenetic alterations in normal cells and cancer risk.正常细胞中遗传和表观遗传改变的积累与癌症风险。
NPJ Precis Oncol. 2019 Mar 6;3:7. doi: 10.1038/s41698-019-0079-0. eCollection 2019.
9
Osteogenesis depends on commissioning of a network of stem cell transcription factors that act as repressors of adipogenesis.成骨作用依赖于一组干细胞转录因子的启动,这些转录因子作为脂肪生成的抑制剂发挥作用。
Nat Genet. 2019 Apr;51(4):716-727. doi: 10.1038/s41588-019-0359-1. Epub 2019 Mar 4.
10
Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and Braf-Induced Tumorigenesis.衰老样自发性表观遗传沉默促进 Wnt 激活、干性和 Braf 诱导的肿瘤发生。
Cancer Cell. 2019 Feb 11;35(2):315-328.e6. doi: 10.1016/j.ccell.2019.01.005.